A Japan-based pharmaceutical developer focused on prescription drugs for central nervous system disorders, immunology, inflammation, and metabolic diseases. The company conducts global research and commercialization of therapies and operates as part of the Mitsubishi Chemical Group, giving it access...
1 member of Congress has disclosed 1 trade in MITSUBISHI TANABE PHARMA CORP SPON ADR (MTBCY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-07-10 | Ted S. Yoho | sell | $4K+ |